statements

Shree Ganesh Remedies Ltd.

BSE: 540737

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

640.40-5.6 (-0.87%)

27 Jul, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Shree Ganesh Remedies Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	19.86	15.52	16.50	15.52	19.86	27.26	35.31	58.43	49.08	71.29	90.22	125.90	108.60	109.29
Cost of Operating Revenue	10.58	9.15	9.98	9.15	10.58	15.51	19.53	37.84	24.74	40.36	50.86	70.98	53.63	52.35
Gross Profit	9.28	6.37	6.52	6.37	9.28	11.75	15.78	20.59	24.34	30.93	39.36	54.92	54.96	56.94
Gross Margin	46.7	41.1	39.5	41.1	46.7	43.1	44.7	35.2	49.6	43.4	43.6	43.6	50.6	52.1
Total Operating Expenses	16.36	14.20	14.97	14.20	16.36	22.67	27.61	49.72	38.16	56.71	70.68	90.19	78.95	84.74
Operating Profit	3.50	1.32	1.53	1.32	3.50	4.59	7.71	8.71	10.92	14.58	19.54	35.70	29.64	24.55
Operating Margin	17.6	8.5	9.3	8.5	17.6	16.8	21.8	14.9	22.3	20.5	21.7	28.4	27.3	22.5
Financing Income/(Expense) - Net	-0.04	-0.04	-0.12	-0.04	-0.04	-0.10	-0.20	-0.14	-0.07	-0.15	-0.12	1.85	0.15	-3.56
Profit before Taxes	3.92	1.63	1.91	1.63	3.92	6.48	8.67	12.74	12.95	18.01	22.58	38.16	31.27	24.01
Income Taxes	1.31	0.55	0.63	0.55	1.31	1.79	2.43	3.12	3.20	4.61	5.56	10.05	8.20	6.25
Profit after Tax	2.61	1.08	1.27	1.08	2.61	4.69	6.24	9.62	9.75	13.40	17.02	28.11	23.07	17.76
PAT Margin	13.2	7.0	7.7	7.0	13.2	17.2	17.7	16.5	19.9	18.8	18.9	22.3	21.2	16.3
EPS - Basic - ex Extraordinary Items	2.09	0.87	1.02	0.87	2.09	4.38	4.95	7.64	7.75	10.64	13.86	22.34	17.96	13.83
EPS - Diluted - ex Extraordinary Items	2.09	0.87	1.02	0.87	2.09	4.38	4.95	7.64	7.75	10.64	13.86	22.34	17.96	13.83
EBIT	3.50	1.32	1.53	1.32	3.50	4.59	7.71	8.71	10.92	14.58	19.54	35.70	29.64	24.55
EBITDA	4.04	1.92	2.18	1.92	4.04	5.19	8.77	10.95	13.65	17.92	23.26	41.81	39.21	35.02
EBITDA Margin	20.4	12.4	13.2	12.4	20.4	19.0	24.8	18.7	27.8	25.1	25.8	33.2	36.1	32.0

Balance Sheet

Abridged

Understanding Balance Sheet

Shree Ganesh Remedies Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	PR	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	8.30	9.86	10.49	11.06	16.63	28.75	25.81	33.82	37.99	44.91	64.29	70.20	77.58	85.86
Long-Term Investments	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.07	0.07	1.77	1.42	0.08	0.08	2.51
Property Plant & Equipment - Net	3.90	4.43	4.49	4.34	4.19	6.10	14.42	18.67	20.29	29.82	76.45	97.11	103.31	117.01
Total Non-Current Assets	4.14	4.66	4.75	4.60	4.50	6.88	15.53	21.46	22.61	32.11	79.54	100.73	114.37	121.82
Total Assets	12.44	14.52	15.25	15.67	21.13	35.62	41.34	55.28	60.60	77.02	143.83	170.94	191.94	207.69
Total Current Liabilities	3.45	2.59	2.13	1.51	4.44	6.51	6.79	10.38	10.19	15.04	23.74	18.68	16.18	21.69
Long Term Debt	0.34	0.06	0.02	-	-	0.21	0.24	2.20	-	-	30.93	29.24	29.61	21.38
Total Non-Current Liabilities	0.54	0.27	0.22	0.17	0.19	0.44	0.73	2.65	0.41	0.40	31.16	30.16	30.60	23.03
Total Liabilities	4.00	2.86	2.34	1.68	4.63	6.95	7.52	13.03	10.59	15.44	54.90	48.84	46.79	44.72
Total Shareholders' Equity	8.44	11.66	12.90	13.99	16.50	28.67	33.82	42.20	50.00	61.57	88.94	122.10	145.16	162.97
Minority Interest	-	-	-	-	-	-	-	0.04	-	-	-	-	-	-
Total Equity	8.44	11.66	12.90	13.99	16.50	28.67	33.82	42.25	50.00	61.57	88.94	122.10	145.16	162.97
Total Liabilities & Equity	12.44	14.52	15.25	15.67	21.13	35.62	41.34	55.28	60.60	77.02	143.83	170.94	191.94	207.69

Cash Flow

Abridged

Understanding Cash Flow Statement

Shree Ganesh Remedies Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	C 2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M IR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-0.27	0.10	-0.71	-0.77	-0.38	6.57	3.61	7.19	5.11	15.52	20.71	35.39	30.37	27.28
Working Capital - Increase/(Decrease)	1.03	4.45	-0.56	-0.73	2.17	-7.48	-9.15	-3.31	-1.80	-2.10	-3.69	-5.47	-1.73	-7.07
Net CF from Operating Activities	0.75	4.55	-1.27	-1.50	1.80	-0.91	-5.55	3.88	3.31	13.42	17.01	29.92	28.63	20.21
Capital Expenditures - Net	0.00	0.00	0.00	0.03	-0.15	-0.62	0.10	0.04	0.01	15.33	51.55	31.13	23.18	16.58
Net CF from Investing Activities	0.03	-1.03	0.98	1.33	0.10	-3.45	-0.08	-2.91	-0.94	-11.91	-53.57	-33.07	-35.68	-9.95
Dividends Paid - Cash - Total	-	-	-	-	-	-	-	-	-	1.61	0.60	0.63	-	-
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	2.38	-	-	-	-	11.00	7.37	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-0.65	-0.36	-0.39	-0.04	-0.02	-0.10	-0.18	-0.21	-0.71	-0.08	30.93	3.70	0.96	-8.10
Net Cash Flow from Financing Activities	-0.65	-0.36	-0.39	-0.04	-0.02	8.14	-0.18	-0.21	-0.66	-1.69	41.33	10.44	0.96	-8.10
Free Cash Flow to Equity	0.10	4.19	-1.66	-1.57	1.92	-0.38	-5.82	3.63	2.60	-1.99	-3.61	2.48	6.42	-4.48
Free Operating CF net dividend	0.75	4.55	-1.27	-1.53	1.80	-0.91	-5.64	3.83	3.30	-3.52	-35.17	-1.85	5.44	3.61
Free Operating CF	0.75	4.55	-1.27	-1.53	1.80	-0.91	-5.64	3.83	3.30	-1.91	-34.57	-1.22	5.44	3.61

Business Segment Analysis

FY End:

Mar 25

Shree Ganesh Remedies Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Bulk drug intermediates (100.0%)₹ 23.20 Cr

Revenue / Sales

Bulk drug intermediates (100.0%)₹ 108.60 Cr

Assets

Bulk drug intermediates (100.0%)₹ 191.94 Cr

Operating Income

Bulk drug intermediates (100.0%)₹ 29.64 Cr

Regional Segment Analysis

FY End:

Mar 25

Shree Ganesh Remedies Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Outside India (61.8%)₹ 67.09 CrIndia (38.2%)₹ 41.51 Cr

Historical Segment Analysis

Track how Shree Ganesh Remedies Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2023 Mar 31	2024 Mar 31	2025 Mar 31

Bulk drug intermediates	52	31	23

Frequently Asked Questions

What is the revenue of Shree Ganesh Remedies Ltd.?

The latest trailing twelve month revenue of Shree Ganesh Remedies Ltd. is ₹ 109.29 Cr, reflecting a 1-year growth of 0.64% and a 3-year CAGR of 6.60%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Shree Ganesh Remedies Ltd.?

The latest trailing twelve month net profit (PAT) of Shree Ganesh Remedies Ltd. is ₹ 17.76 Cr, with a 3-year earnings CAGR of -0.08%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Shree Ganesh Remedies Ltd.?

The trailing twelve month EBITDA of Shree Ganesh Remedies Ltd. is approximately ₹ 24.55 Cr (based on an operating margin of 22.46%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Shree Ganesh Remedies Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Shree Ganesh Remedies Ltd. is 13.83. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Shree Ganesh Remedies Ltd.?

The debt-to-equity ratio of Shree Ganesh Remedies Ltd. stands at 0.19. The interest coverage ratio is 6.89x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Shree Ganesh Remedies Ltd.?

The estimated book value per share of Shree Ganesh Remedies Ltd. is 126.85 (derived from a P/B ratio of 5.05 and market price of ₹ 640.40), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Shree Ganesh Remedies Ltd.?

The trailing twelve month operating cash flow of Shree Ganesh Remedies Ltd. is ₹ 20.21 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Shree Ganesh Remedies Ltd. report consolidated or standalone financials?

Shree Ganesh Remedies Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.